Subjective Measures of Efficacy: Quality of Life, Patient Satisfaction and Patient-Oriented Goals - the Search for Value{A figure is presented}

European Urology, Supplements

Volumn 6, Issue 5, 2007, Pages 438-443

  Sand, Peter K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antimuscarinic therapy; Overactive bladder; Quality of life; Therapeutic index; Value

Indexed keywords

DARIFENACIN; OXYBUTYNIN; SOLIFENACIN; TOLTERODINE; TROSPIUM CHLORIDE;

ARTICLE; CALCULATION; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; MEASUREMENT; NOCTURIA; OUTCOME ASSESSMENT; OVERACTIVE BLADDER; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; UNITED STATES; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE; XEROSTOMIA;

EID: 33846704713     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2006.12.013     Document Type: Article

References (18)

1. Abrams P., Cardozo L., Fall M., et al. The standardization of terminology of lower urinary tract function: report from the Standardization Sub-Committee of the International Continence Society. Neurourol Urodyn 21 (2002) 67-78
2. Ware Jr. J.E., Kosinski M., Bayliss M.S., McHorney C.A., Rogers W.H., and Raczak A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33 4 Suppl (1995) AS264-AS279
3. Van der Vaart C.H., de Leeuw J.R., Roovers J.P., and Heintz A.P. Measuring health-related quality of life in women with urogenital dysfunction: the urogenital distress inventory and incontinence impact questionnaire revisited. Neurourol Urodyn 22 (2003) 97-104
4. Coyne K.S., Revicki D.A., Hunt T., et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11 (2002) 563-574
5. Kelleher C.J., Cardozo L.D., Khullar V., and Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. BJOG 104 (1997) 1374-1379
6. Kelleher C.J., Pleil A.M., Reese P.R., Burgess S.M., and Brodish P.H. How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder. BJOG 111 (2004) 605-612
7. Physicians' Desk Reference. Montvale, NJ: Thompson PDR; 2006. p. 2629-31.
8. Physicians' Desk Reference. Montvale, NJ: Thompson PDR; 2006. p. 2391-3.
9. Physicians' Desk Reference. Montvale, NJ: Thompson PDR; 2006. p. 3383-5.
10. Physicians' Desk Reference. Montvale, NJ: Thompson PDR; 2006. p. 1133-5.
11. Physicians' Desk Reference. Montvale, NJ: Thompson PDR; 2006. p. 631-4.
12. Physicians' Desk Reference. Montvale, NJ: Thompson PDR; 2006. p. 2201-4.
13. Staskin D.R., and Wein A. Is it possible to make cross-study comparisons of urinary continence rates in patients with overactive bladder?. Curr Med Res Opin 21 (2005) 835-837
14. Sand P.K., and Brubaker L.T. Advances in non-operative treatment of genuine stress incontinence. Curr Opin Obstet Gynecol 2 (1990) 599-604
15. Benson K., and Hartz A.J. A comparison of observational studies and randomized, controlled trials. N Engl J Med 342 (2000) 1878-1886
16. Khullar V., Chapple C., Gabriel Z., and Dooley J.A. The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis. Urology 68 2 Suppl (2006) 38-48
17. UCB Pharma. Data on file.
18. Homma Y., and Koyama N. Minimal clinically important change in urinary incontinence detected by a quality of life assessment tool in overactive bladder syndrome with urge incontinence. Neurourol Urodyn 25 (2006) 228-235